| «Ce qui me gêne, ce n’est pas mon âge…». Diagnostic de glomérulonéphrite à dépôt de C3 sur mutation hétérozygote du facteur H chez une femme de 96 ans C Boud’hors, V Milon, JP Coindre, M Torreggiani, A Croue, ... Néphrologie & Thérapeutique 17 (5), 328, 2021 | | 2021 |
| # 1668 The 60: 40 conundrum: are women with CKD discriminated against after referral to a nephrology clinic? A Vautcranne, L Bianco, B Mazé, A Fois, A Chatrenet, MR Moio, ... Nephrology Dialysis Transplantation 39 (Supplement_1), gfae069-1425-1668, 2024 | | 2024 |
| # 1728 New onset proteinuria in two pregnancies: glomerulopathy or preeclampsia? G Chimenti, A Magli, L Njandjo, A Fois, G Santagati, G Piccoli, ... Nephrology Dialysis Transplantation 39 (Supplement_1), gfae069-1265-1728, 2024 | | 2024 |
| A Combination of an Anti-Inflammatory Drug, Pentosan Polysulfate (PPS), and an Anti-AGE Drug, Pyridoxamine (PYR), Decreases Kidney Disease in Diabetic CD-1 Mice F Grosjean, M Torreggiani, V Esposito, W Cai, H Vlassara, F Zheng, ... DIABETES 59, A249-A250, 2010 | | 2010 |
| A QUALCUNO PIACE CALDO M Torreggiani | | |
| A tale of two cells M Torreggiani Giornale italiano di nefrologia: organo ufficiale della Societa italiana di …, 2012 | | 2012 |
| A young patient with back pain M Torreggiani, V Esposito, C Esposito European Journal of Internal Medicine 52, e5-e6, 2018 | | 2018 |
| Adding creatinine to routine pregnancy tests: a decision tree for calculating the cost of identifying patients with CKD in pregnancy GB Piccoli, A Chatrenet, M Cataldo, M Torreggiani, R Attini, B Masturzo, ... Nephrology Dialysis Transplantation 38 (1), 148-157, 2023 | 10 | 2023 |
| Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia M Torreggiani, H Liu, J Wu, F Zheng, W Cai, G Striker, H Vlassara The American journal of pathology 175 (4), 1722-1732, 2009 | 63 | 2009 |
| AGER1 overexpression protects against acute kidney injury by suppressing endoplasmic reticulum stress, a new mechanism of renal AGE-toxicity R Zhang, M Torreggiani, W Cai, GE Striker, F Zheng, H Vlassara DIABETES 57, A206-A206, 2008 | | 2008 |
| AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-δ: implications for vascular disease W Cai, M Torreggiani, L Zhu, X Chen, JC He, GE Striker, H Vlassara American Journal of Physiology-Cell Physiology 298 (3), C624-C634, 2010 | 93 | 2010 |
| AKI-Experimental K Kaynar, K Kaynar, S Ersoz, R Aliyazioglu, A Uzun, S Ulusoy, S Al, ... Nephrology Dialysis Transplantation 27 (2), ii333, 2012 | | 2012 |
| Analysis of the rate of force development reveals high neuromuscular fatigability in elderly patients with chronic kidney disease A Chatrenet, G Piccoli, JM Audebrand, M Torreggiani, J Barbieux, ... Journal of Cachexia, Sarcopenia and Muscle 14 (5), 2016-2028, 2023 | 4 | 2023 |
| Any reduction in maternal kidney mass makes a difference during pregnancy in gestational and fetal outcome GB Piccoli, R Attini, M Torreggiani, A Chatrenet, AM Manzione, ... Kidney International, 2024 | | 2024 |
| APOLIPOPROTEIN A-II AMYLOIDOSIS (AApoAII) IS ASSOCIATED WITH KIDNEY AGING AND INCREASED EXPRESSION OF INFLAMMASOME RELATED MOLECULES IN CD-1 MICE F Grosjean, C Tribioli, V Esposito, D Catucci, G Azar, M Torreggiani, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 28, 411-412, 2013 | | 2013 |
| Are randomized trials the best way to test different dialysis initiation regimens? M Torreggiani, A Fois, H Fessi, GB Piccoli Kidney International 102 (1), 208-209, 2022 | 2 | 2022 |
| Are randomized trials the best way to test different dialysis initiation regimens? reply M Torreggiani, A Fois, H Fessi, GB Piccoli KIDNEY INTERNATIONAL 102 (1), 209-209, 2022 | | 2022 |
| Baseline proteinuria level and adverse outcomes in pregnant women with chronic kidney disease: new evidence and a note of caution D Kervella, M Torreggiani Clinical Kidney Journal 16 (10), 1550-1552, 2023 | 1 | 2023 |
| Ca-P metabolism: wind of change? M Torreggiani Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di …, 2013 | | 2013 |
| Calcineurin inhibitors treatment is associated with increased asymmetrical dimethylarginine (ADMA) plasma levels in kidney transplant recipients C Esposito, A Plati, A DAL CANTON, M Torreggiani, F Grosjean, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 21 (Suppl 4), 535-536, 2006 | | 2006 |
Esposito CiroProfessore Associato di Nefrologia, Responsabile UOC Nefrologia e Dialisi, Fondazione IRCCS S. Mauge在 unipv.it 的电子邮件经过验证
